Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 14 of 14 entries
View as:

Methylprednisolone in COVID-19 Patients (Methyl19LGH)

Phase: N/A Priority: Normal
NCT ID: NCT04559113 Org: User:
Start: 05/01/20 End: 12/30/20 Due: 12/30/21

Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs

Phase: N/A Priority: Normal
NCT ID: NCT04563247 Org: User:
Start: 07/01/20 End: 02/08/21 Due: 02/08/22

Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06889909 Org: User:
Start: 12/15/24 End: 06/15/25 Due: 06/15/26

Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

Phase: N/A Priority: Normal
NCT ID: NCT06872372 Org: User:
Start: 01/15/25 End: 07/15/25 Due: 07/15/26

High Flow Nasal Cannula HFNC In Covid-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04560257 Org: User:
Start: 05/01/20 End: 12/30/20 Due: 12/30/21

Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population

Phase: N/A Priority: Normal
NCT ID: NCT04568850 Org: User:
Start: 07/01/20 End: 02/28/22 Due: 02/28/23

Exercise Training Versus Ropinirole in Treating Restless Legs Syndrome Among Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT06468371 Org: User:
Start: 01/02/22 End: 02/01/24 Due: 02/01/25

Seroconversion in COVID-19 Recovered Population

Phase: N/A Priority: Normal
NCT ID: NCT04558385 Org: User:
Start: 07/01/20 End: 03/31/21 Due: 03/31/22

Tocilizumab in COVID-19 Lahore General Hospital

Phase: N/A Priority: Normal
NCT ID: NCT04560205 Org: User:
Start: 05/01/20 End: 12/30/20 Due: 12/30/21

Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT06425705 Org: User:
Start: 02/25/22 End: 07/10/23 Due: 07/10/24

Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT06838104 Org: User:
Start: 12/05/24 End: 06/05/25 Due: 06/05/26

Remdesivir in COVID-19 Lahore General Hospital

Phase: N/A Priority: Normal
NCT ID: NCT04560231 Org: User:
Start: 06/01/20 End: 11/30/20 Due: 11/30/21

Booster Effect of mRNA Vaccine on Antibody Response for SARS-CoV-2 After Complete Vaccination With Sinos

Phase: N/A Priority: Normal
NCT ID: NCT05213455 Org: User:
Start: 01/01/22 End: 03/15/22 Due: 03/15/23

Convalescent Plasma Therapy for COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04565197 Org: User:
Start: 05/01/20 End: 12/30/20 Due: 12/30/21